Skip to main content
Log in

Quantitative imaging through the production chain: from idea to application

  • Commentary
  • Published:
Magnetic Resonance Materials in Physics, Biology and Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Weingärtner S et al (2022) Development, validation, qualification, and dissemination of quantitative MR methods: overview and recommendations by the ISMRM quantitative MR study group. Magn Reson Med 87(3):1184–1206. https://doi.org/10.1002/mrm.29084

    Article  CAS  PubMed  Google Scholar 

  2. Younossi Z et al (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15(1):11–20. https://doi.org/10.1038/nrgastro.2017.109

    Article  PubMed  Google Scholar 

  3. Noureddin M et al (2013) Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatol Baltim Md 58(5):1644–1654. https://doi.org/10.1002/hep.26465

    Article  CAS  Google Scholar 

  4. Tamaki N, Ajmera V, Loomba R (2022) Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nat Rev Endocrinol 18(1):55–66. https://doi.org/10.1038/s41574-021-00584-0

    Article  CAS  PubMed  Google Scholar 

  5. Vilar-Gomez E et al (2018) Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study. Gastroenterology 155(2):443-457.e17. https://doi.org/10.1053/j.gastro.2018.04.034

    Article  PubMed  Google Scholar 

  6. C. for D. and R. Health (2023) Technical performance assessment of quantitative imaging in radiological device premarket submissions. Accessed 23 Oct 2023. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/technical-performance-assessment-quantitative-imaging-radiological-device-premarket-submissions

  7. C. for D. E. and Research (2022) Table of surrogate endpoints that were the basis of drug approval or licensure. FDA. Accessed 23 Oct 2023. https://www.fda.gov/drugs/development-resources/table-surrogate-endpoints-were-basis-drug-approval-or-licensure

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José P. Marques.

Ethics declarations

Conflict of interest

Tom Hilbert is an employee of Siemens Healthineers, Matthew D. Robson is an employee and CTO of Perspectum Ltd, and the remaining co-authors have no conflicts of interest.

Ethical standards

This article does not contain any studies with human participants performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Salameh, N., Weingärtner, S., Hilbert, T. et al. Quantitative imaging through the production chain: from idea to application. Magn Reson Mater Phy 36, 851–855 (2023). https://doi.org/10.1007/s10334-023-01131-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10334-023-01131-w

Navigation